Logo image of CHSN

CHANSON INTERNATIONAL HOLD-A (CHSN) Stock Fundamental Analysis

NASDAQ:CHSN - Nasdaq - KYG2104U1076 - Common Stock - Currency: USD

0.31  +0.03 (+9.15%)

After market: 0.29 -0.02 (-6.45%)

Fundamental Rating

1

CHSN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 40 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and financial health of CHSN have multiple concerns. CHSN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CHSN had negative earnings in the past year.
In the past year CHSN has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: CHSN reported negative net income in multiple years.
Of the past 5 years CHSN 4 years had a positive operating cash flow.
CHSN Yearly Net Income VS EBIT VS OCF VS FCFCHSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 1M -1M -2M -3M

1.2 Ratios

The Return On Assets of CHSN (-0.59%) is worse than 65.00% of its industry peers.
CHSN has a worse Return On Equity (-1.89%) than 65.00% of its industry peers.
Industry RankSector Rank
ROA -0.59%
ROE -1.89%
ROIC N/A
ROA(3y)-0.86%
ROA(5y)0.42%
ROE(3y)-30.34%
ROE(5y)-11.26%
ROIC(3y)N/A
ROIC(5y)N/A
CHSN Yearly ROA, ROE, ROICCHSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 50 -50 -100

1.3 Margins

In the last couple of years the Profit Margin of CHSN has declined.
The Gross Margin of CHSN (43.43%) is better than 90.00% of its industry peers.
CHSN's Gross Margin has been stable in the last couple of years.
CHSN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-50.19%
GM growth 3Y-1.85%
GM growth 5Y-0.97%
CHSN Yearly Profit, Operating, Gross MarginsCHSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 20 40

1

2. Health

2.1 Basic Checks

CHSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CHSN has been increased compared to 1 year ago.
The number of shares outstanding for CHSN has been increased compared to 5 years ago.
CHSN has a worse debt/assets ratio than last year.
CHSN Yearly Shares OutstandingCHSN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
CHSN Yearly Total Debt VS Total AssetsCHSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of 0.36, we must say that CHSN is in the distress zone and has some risk of bankruptcy.
CHSN has a Altman-Z score of 0.36. This is amonst the worse of the industry: CHSN underperforms 85.00% of its industry peers.
CHSN has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
CHSN has a better Debt to Equity ratio (0.26) than 67.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 0.36
ROIC/WACCN/A
WACC6.62%
CHSN Yearly LT Debt VS Equity VS FCFCHSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 5M 10M

2.3 Liquidity

CHSN has a Current Ratio of 0.71. This is a bad value and indicates that CHSN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.71, CHSN is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
CHSN has a Quick Ratio of 0.71. This is a bad value and indicates that CHSN is not financially healthy enough and could expect problems in meeting its short term obligations.
CHSN has a Quick ratio of 0.66. This is comparable to the rest of the industry: CHSN outperforms 57.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.66
CHSN Yearly Current Assets VS Current LiabilitesCHSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 5M 10M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 84.28% over the past year.
CHSN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -45.44% yearly.
Looking at the last year, CHSN shows a very negative growth in Revenue. The Revenue has decreased by -27.62% in the last year.
Measured over the past years, CHSN shows a small growth in Revenue. The Revenue has been growing by 7.60% on average per year.
EPS 1Y (TTM)84.28%
EPS 3YN/A
EPS 5Y-45.44%
EPS Q2Q%-92.88%
Revenue 1Y (TTM)-27.62%
Revenue growth 3Y18.72%
Revenue growth 5Y7.6%
Sales Q2Q%-14.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSN Yearly Revenue VS EstimatesCHSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 5M 10M 15M

0

4. Valuation

4.1 Price/Earnings Ratio

CHSN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSN Price Earnings VS Forward Price EarningsCHSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CHSN Per share dataCHSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CHSN!.
Industry RankSector Rank
Dividend Yield N/A

CHANSON INTERNATIONAL HOLD-A

NASDAQ:CHSN (4/17/2025, 8:08:58 PM)

After market: 0.29 -0.02 (-6.45%)

0.31

+0.03 (+9.15%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.26%
Inst Owner ChangeN/A
Ins Owners38.85%
Ins Owner ChangeN/A
Market Cap8.46M
AnalystsN/A
Price TargetN/A
Short Float %3.22%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.53
P/FCF N/A
P/OCF N/A
P/B 0.7
P/tB 0.71
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.59
BVpS0.44
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.59%
ROE -1.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.43%
FCFM N/A
ROA(3y)-0.86%
ROA(5y)0.42%
ROE(3y)-30.34%
ROE(5y)-11.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-50.19%
GM growth 3Y-1.85%
GM growth 5Y-0.97%
F-Score3
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 92.17%
Cap/Sales 5.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.66
Altman-Z 0.36
F-Score3
WACC6.62%
ROIC/WACCN/A
Cap/Depr(3y)189.46%
Cap/Depr(5y)164.77%
Cap/Sales(3y)8.57%
Cap/Sales(5y)7.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.28%
EPS 3YN/A
EPS 5Y-45.44%
EPS Q2Q%-92.88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.62%
Revenue growth 3Y18.72%
Revenue growth 5Y7.6%
Sales Q2Q%-14.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-167.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-530.94%
OCF growth 3YN/A
OCF growth 5YN/A